Variant angina (VA) is described as a relatively benign syndrome of unprovoked chest pain and electrocardiographic (ECG) changes. Chronic kidney disease (CKD) may be associated with this syndrome. However, the incidence of severe manifestations of VA in this patient cohort with kidney disease has not been elucidated. Also, no description has been made of coronary vasospam in relation to dialysis sessions. Our patient, a young female with CKD, had an unusual history of angina following dialysis sessions and she suffered an acute coronary syndrome complicated by cardiac arrest. The diagnosis was made on the basis of her clinical features, dynamic ECG changes, and coronary angiogram findings, and the patient was managed medically. Severe manifestations of VA may occur in chronic kidney disease, and this should be kept in mind by the treating physician. The association of coronary vasospasm with dialysis needs further analysis.
Introduction
Variant angina (VA) is an uncommon syndrome that is mostly benign but carries a serious risk of myocardial infarction (MI), syncope, ventricular arrhythmias, and sudden cardiac death.
1,2 Cardiovascular complications are well known in chronic kidney disease (CKD). Coronary vasospasm has been described as a cause of chest pain in kidney disease, but details of its incidence and manifestations have not been elucidated. 3, 4 Also, various haemodynamic changes occur during haemodialysis, but its acute effect on coronary circulation is not well understood. We report a rare case of VA in a young patient with CKD who presented with MI and cardiac arrest secondary to ventricular fibrillation (VF). We also describe the therapeutic dilemma we encountered during management.
Learning points
• Chronic kidney disease (CKD) is known to be associated with coronary vasospasm, which may present with severe manifestations. The association of haemodialysis with variant angina needs further analysis.
• Severe localized coronary spasm can angiographically mimic organic stenosis and should thereby be kept in mind while performing primary percutaneous coronary intervention. 
Timeline Patient information and physical examination
A 46-year-old premenopausal female, non-smoker, hypertensive with CKD on maintenance haemodialysis, with known atrial fibrillation (AF), presented to our hospital with chest pain and was diagnosed as a case of acute coronary syndrome.
The patient had this episode of severe angina for 45 minutes, following a session of haemodialysis. On enquiry, she complained of recurrent episodes of angina at rest, following her haemodialysis sessions since few months which resolved with nitroglycerine spray.
She had an irregular pulse with a rate of approximately 110/ minutes, with a normal blood pressure at presentation. Cardiovascular examination showed variable first heart sound, normal second heart sound, and no additional sounds or murmurs. Respiratory examination was unremarkable with equal air entry and no foreign sounds.
Diagnostic assessment and interventions
Electrocardiogram (ECG) revealed AF with ST-segment elevation in Leads I and aVL, suggestive of high lateral wall MI ( Figure 1 ). The serum troponin I level was 10 ng/mL (normal <20 ng/mL), and the 2D echo examination was normal with no wall motion abnormality. Other blood investigations were normal, except for high serum creatinine of 4.85 mg/dL (normal 0.57-1.11 mg/dL). Approximately 20 minutes after admission, patient developed an episode of VF leading to cardiac arrest and was successfully resuscitated with a single DC shock of 200 J, a single intravenous bolus of 1 mg adrenaline, and five cycles of cardiopulmonary resuscitation (CPR). Following the cardiac arrest, the patient was shifted for an emergency percutaneous coronary intervention (PCI) on inotropic support with dopamine injection. Coronary angiogram revealed >90% stenosis in mid-left anterior descending artery (LAD) and non-significant disease in the left circumflex artery and the right coronary artery ( Figure 2 ).
As the patient was a premenopausal female with a history of nonexertional angina resolving with nitroglycerine and had no obvious thrombus or dissection in the culprit artery, vasospasm of the LAD was suspected to be the likely aetiology of her presentation.
Although an ergonovine provocative test would have been ideal for diagnosis, we refrained from performing it as the patient had been 
Follow-up and outcomes
On follow-up at 1 month, the patient was asymptomatic, tolerating her medications well and was compliant to therapy. Following discharge, she underwent eight haemodialysis sessions without any clinical event. Baseline ECG showed AF and no ST-T changes.
Discussion
To our knowledge, this is the first reported case of a patient with CKD having VA with complication of VF leading to cardiac arrest. The association of angina following haemodialysis presumably due to coronary vasospasm has also not been described.
Pathophysiology and association with chronic kidney disease
The association of coronary vasospasm with renal impairment has been shown to be high in certain study populations. 3, 4 Endothelial dysfunction 3 and chronic inflammation 4 are probable factors that play a role in the pathogenesis of VA in these patients. An association of VA with elevated levels of C-reactive protein (CRP) in patients with CKD has been shown. 4 Our patient had very high-sensitivity CRP levels of 15.1 mg/dL (normal <0.5 mg/dL). Few uraemic toxins are also associated with endothelial dysfunction and immune dysregulation.
5
Although peripheral vasoconstriction is known following haemodialysis, 6 no description could be found associating coronary vasospasm to dialysis. Low levels of nitric oxide end products and elevated endothelin-1 levels have been isolated in patients who develop hypertension during and after dialysis. 7 These mechanisms might have played a role in the pathophysiology of coronary vasospasm in our patient. 
Severe manifestations of variant angina
Lethal arrhythmias and high-degree atrioventricular block are known in VA. 1, 2, 8 Coronary artery spasm-induced cardiac death has been described in patients. 8 Our patient had an episode of VF leading to cardiac arrest.
Therapeutic dilemma
Management of cardiac arrest: Some case reports have described the use of nitrates during VA-induced cardiac arrest with successful outcome by avoiding adrenaline. 9, 10 In our patient, we, however, gave adrenaline during CPR and did not find it detrimental. Role of percutaneous coronary interventions: Percutaneous coronary intervention has been done in patients of VA with organic obstructive coronary artery stenosis 11 and even in patients with normal coronaries who were resistant to medical therapy. 12 However, larger studies are needed before recommending PCI as a treatment for VA. Role of implantable cardioverter defibrillators: Variant angina and lethal arrhythmias have been reported in patients with silent ST-segment elevation. 13 Matsue et al. 14 recommended implanting ICD in every VA patient with lethal arrhythmia, irrespective of response to medical therapy. However, general consensus is that patients of VA with recurrent ventricular tachyarrhythmias, despite optimal medical therapy, should be considered for implantable cardioverter defibrillators (ICDs). 15 Hence, we decided not to implant an ICD in our patient.
Conclusion
(1) Variant angina (VA) can present with severe manifestations like myocardial infarction, ventricular arrhythmias, and even cardiac arrest. (2) Chronic kidney disease may be associated with coronary vasospasm.
The association of haemodialysis with VA needs further analysis. (3) Severe localized coronary spasm can angiographically mimic organic stenosis and should thereby be kept in mind while performing primary percutaneous coronary intervention. (4) Definite scientific evidence is lacking for several treatment issues of VA. Hence, management of every case should be individualized.
Patient perspective
Patient was satisfied with her treatment and her only concern was regarding the need for an ICD, for which she has been advised follow-up at present.
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